Loading…
NYXH
Nyxoah SA
NASDAQ· Healthcare· Medical Instruments & Supplies· CUSIP B6S7WD106
$1.60+1.91%Price as of Aug 29, 18:39 UTC · updated once a day, after the close
Key metrics
- Market cap
- $162.94M
- P/E
- —
- Forward P/E
- —
- P/B
- 1.7x
- Dividend yield
- —
- Payout
- —
- EPS
- -$2.56
- ROE
- -122.68%
- Profit margin
- 0.00%
- Revenue growth
- +472.80%
- Beta
- 0.95
- 52-week high
- $6.88
- 52-week low
- $1.26
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -94.2% over 5Y.
today you would have $49.58▼ -95.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $4.60 | $8.00 | $4.64 | $4.99 | |
| P/S | 36.2x | 19.8x | 66.2x | 30.6x | 41.8x |
| P/B | 2.0x | 4.0x | 2.6x | 1.4x | 1.1x |
| EPS | -$2.36 | -$1.81 | -$1.55 | -$1.21 | |
| Profit margin | -1003.16% | -899.05% |
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| MDWDMediWound Ltd. | $12.66 | — | 4.6x | — | -72.37% | $163.44M |
| LFMDLifeMD, Inc. | $3.30 | — | 19.8x | — | -515.90% | $159.06M |
| BNRBurning Rock Biotech Ltd | $15.08 | — | 2.2x | — | -12.82% | $158.99M |
| CLLSCellectis S.A. | $1.56 |
About the company
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- 153
- Mont-Saint-Guibert, Belgium
Company description provided by Yahoo Finance.